{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:54Z","timestamp":1787020494091,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12916-015-0291-x","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T16:07:58Z","timestamp":1426694878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?"],"prefix":"10.1186","volume":"13","author":[{"given":"Neville D","family":"Yeomans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,19]]},"reference":[{"key":"291_CR1","first-page":"CD004257","volume":"1","author":"TE Towheed","year":"2006","unstructured":"Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006;1:CD004257.","journal-title":"Cochrane Database Syst Rev"},{"key":"291_CR2","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","volume":"160","author":"S Hernandez-Diaz","year":"2000","unstructured":"Hernandez-Diaz S, Rodriguez LAG. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation. Arch Intern Med. 2000;160:2093\u20139.","journal-title":"Arch Intern Med"},{"key":"291_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 1971;231:232\u20135.","journal-title":"Nature New Biol"},{"key":"291_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2474-8-73","volume":"3","author":"RA Moore","year":"2007","unstructured":"Moore RA, Derry S, McQuay HJ. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk. BMC Musculoskelet Disord. 2007;3:73.","journal-title":"BMC Musculoskelet Disord"},{"key":"291_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cgh.2007.03.011","volume":"5","author":"A Rostom","year":"2007","unstructured":"Rostom A, Muir K, Dub\u00e9 C, Jolicoeur E, Boucher M, Joyce J, et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol. 2007;5:818\u201328.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"291_CR6","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","volume":"343","author":"C Bombardier","year":"2000","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520\u20138.","journal-title":"N Engl J Med"},{"key":"291_CR7","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.106.636746","volume":"114","author":"SD Solomon","year":"2006","unstructured":"Solomon SD, Pfeffer MA, McMurray JJ, Fowler R, Finn P, Levin B, et al. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation. 2006;114:1028\u201335.","journal-title":"Circulation"},{"key":"291_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352:1092\u2013102.","journal-title":"N Engl J Med"},{"key":"291_CR9","unstructured":"European Medicines Agency concludes action on COX-2 inhibitors. 2005. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2010\/01\/news_detail_000969.jsp&mid=WC0b01ac058004d5c1 ."},{"key":"291_CR10","unstructured":"Jenkins JK, Seligman PJ. Analysis and recommendations for Agency action regarding non-steroidal anti-inflammatory drugs and cardiovascular risk. April 6, 2005. http:\/\/www.fda.gov\/downloads\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ucm106201.pdf ."},{"key":"291_CR11","unstructured":"FDA, Transcript for the February 11, 2014 Joint Meeting of the Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management Advisory Committee. 2014. www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/ArthritisAdvisoryCommittee\/UCM398864.pdf"},{"key":"291_CR12","doi-asserted-by":"crossref","unstructured":"Scarpignato C, Lanas A, Blandizzi C, Lems WF, Hermann M, Hunt R; for International NSAID Consensus Group. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis: an expert consensus addressing benefits and gastrointestinal as well as cardiovascular risks. BMC Med. 2015;13.","DOI":"10.1186\/s12916-015-0285-8"},{"key":"291_CR13","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","volume":"115","author":"EM Antman","year":"2007","unstructured":"Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115:1634\u201342.","journal-title":"Circulation"},{"key":"291_CR14","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","volume":"52","author":"DL Bhatt","year":"2008","unstructured":"Bhatt DL, Scheiman J, Abraham NS, Antman EN, Chan FKL, Ferburg KD, et al. ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation task force on clinical expert consensus documents. J Amer Coll Cardiol. 2008;52:1502\u20137.","journal-title":"J Amer Coll Cardiol"},{"key":"291_CR15","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1111\/j.1572-0241.2008.02200.x","volume":"103","author":"FK Chan","year":"2008","unstructured":"Chan FK, Abraham NS, Scheiman JM, Laine L. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol. 2008;103:2908\u201318.","journal-title":"Am J Gastroenterol"},{"key":"291_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2036.2008.03905.x","volume":"29","author":"A Rostom","year":"2009","unstructured":"Rostom A, Moayyedi P, Hunt R, Canadian Association of Gastroenterology Consensus Group. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther. 2009;29:481\u201396.","journal-title":"Aliment Pharmacol Ther"},{"key":"291_CR17","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","volume":"330","author":"C Patrono","year":"1994","unstructured":"Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994;330:1287\u201394.","journal-title":"N Engl J Med"},{"key":"291_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/j.1552-4604.1995.tb04050.x","volume":"35","author":"AI Schafer","year":"1995","unstructured":"Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995;35:209\u201319.","journal-title":"J Clin Pharmacol"},{"key":"291_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/jps.2600610507","volume":"61","author":"R Runkel","year":"1972","unstructured":"Runkel R, Chaplin M, Boost G, Segre E, Forchielli E. Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J Pharmaceut Sci. 1972;61:703\u20138.","journal-title":"J Pharmaceut Sci"},{"key":"291_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-0609.1984.tb02390.x","volume":"33","author":"S Cronberg","year":"1984","unstructured":"Cronberg S, Wallmark E, S\u00f6derberg I. Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand J Haematol. 1984;33:155\u20139.","journal-title":"Scand J Haematol"},{"key":"291_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration","year":"2013","unstructured":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769\u201379.","journal-title":"Lancet"},{"key":"291_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ahj.2008.12.014","volume":"157","author":"MC Becker","year":"2009","unstructured":"Becker MC, Wang TH, Wisniewski L, Wolski K, Libby P, L\u00fcscher TF, et al. Rationale, design, and governance of prospective randomized evaluation of celecoxib integrated safety versus ibuprofen or naproxen (PRECISION), a cardiovascular endpoint trial of non-steroidal anti-inflammatory agents in patients with arthritis. Am Heart J. 2009;157:606\u201312.","journal-title":"Am Heart J"},{"key":"291_CR23","unstructured":"FDA, Center for Drug Evaluation and Research. Summary minutes of the joint meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee, February 10\u201311, 2014. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/ArthritisAdvisoryCommittee\/UCM395527.pdf ."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-015-0291-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0291-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T23:49:33Z","timestamp":1566431373000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-015-0291-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,19]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1186\/s12916-015-0291-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,19]]},"article-number":"56"}}